|
Xometry, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) | |||||||
| Three Months Ended March 31, | |||||||
| 2024 | 2023 | ||||||
| Cash flows from operating activities: | |||||||
| Net loss | $ | (16,604 | ) | $ | (18,343 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Depreciation and amortization | 3,153 | 2,566 | |||||
| Impairment of assets | — | 27 | |||||
| Reduction in carrying amount of right-of-use asset | 1,096 | 1,935 | |||||
| Stock based compensation | 6,036 | 4,694 | |||||
| Revaluation of contingent consideration | 137 | — | |||||
| Income from unconsolidated joint venture | (97 | ) | (66 | ) | |||
| Donation of common stock | 343 | 370 | |||||
| Loss on sale of property and equipment | — | 91 | |||||
| Amortization of deferred costs on convertible notes | 464 | 466 | |||||
| Deferred taxes benefit | — | (23 | ) | ||||
| Changes in other assets and liabilities: | |||||||
| Accounts receivable, net | 532 | (2,804 | ) | ||||
| Inventory | (40 | ) | 133 | ||||
| Prepaid expenses | (433 | ) | 185 | ||||
| Other assets | (442 | ) | (3,687 | ) | |||
| Accounts payable | (10,649 | ) | (503 | ) | |||
| Accrued expenses | 4,440 | (2,119 | ) | ||||
| Contract liabilities | 2,277 | 1,436 | |||||
| Lease liabilities | (1,671 | ) | (970 | ) | |||
| Income taxes payable | (276 | ) | 157 | ||||
| Net cash used in operating activities | (11,734 | ) | (16,455 | ) | |||
| Cash flows from investing activities: | |||||||
| Purchases of marketable securities | (2,726 | ) | (2,688 | ) | |||
| Proceeds from sale of marketable securities | 10,000 | — | |||||
| Purchases of property and equipment | (4,347 | ) | (4,186 | ) | |||
| Proceeds from sale of property and equipment | — | 223 | |||||
| Cash paid for business combination, net of cash acquired | — | (3,349 | ) | ||||
| Net cash provided by (used in) investing activities | 2,927 | (10,000 | ) | ||||
| Cash flows from financing activities: | |||||||
| Proceeds from stock options exercised | 1,233 | 483 | |||||
| Net cash provided by financing activities | 1,233 | 483 | |||||
| Effect of foreign currency translation on cash and cash equivalents | (149 | ) | 15 | ||||
| Net decrease in cash and cash equivalents | (7,723 | ) | (25,957 | ) | |||
| Cash and cash equivalents at beginning of the period | 53,424 | 65,662 | |||||
| Cash and cash equivalents at end of the period | $ | 45,701 | $ | 39,705 | |||
| Supplemental cash flow information: | |||||||
| Cash paid for interest | $ | 1,438 | $ | 1,438 | |||
| Non-cash investing and financing activities: | |||||||
| Non-cash purchase of property and equipment | — | 78 | |||||
| Non-cash consideration in connection with business combination | — | 1,593 | |||||
